Anesthesia & Pain Management
NYU College of Dentistry awarded $3.9M grant focusing on chronic pain treatment
September 28, 2020 -- Researchers at New York University (NYU) College of Dentistry have been awarded a $3.9 million grant from the U.S. National Institute of Dental and Craniofacial Research to study chronic pain treatment.
Why you need to know about this acronym -- and why your patients will thank you for it
September 25, 2020 -- Dr. David Rice, clinical editor for DrBicuspid.com, discusses the importance of computer-controlled local anesthetic delivery (CCLAD). He details why this has become a favorite dental acronym of his, and why he believes CCLAD can be a benefit to your practice and patients.  Discuss
FDA awards $1.5M grant to ADA Science & Research Institute
August 28, 2020 -- The ADA announced that the U.S. Food and Drug Administration (FDA) has awarded a three-year, $1.5 million grant to the ADA Science & Research Institute in collaboration with the University of Pittsburgh to develop a clinical practice guideline for the management of acute pain in dentistry, with a focus on the role of opioids.
DEA to raise prescriber fee on October 1
August 3, 2020 -- The U.S. Drug Enforcement Administration (DEA) will raise its prescriber registration fee from $731 to $888 on October 1, according to the California Dental Association.
FDA update: Naloxone and opioid labeling changes
July 28, 2020 -- Tom Viola, RPh, explains why dentists may want to know about naloxone and why it is being discussed currently by the U.S. Food and Drug Administration (FDA) in connection with opioid use disorder.  Discuss
What to know about antibiotics and the risk of cardiovascular death
July 9, 2020 -- The relative safety of azithromycin was first questioned following a study published in 2012, which reported an association between azithromycin use and sudden cardiac death. Now Tom Viola, RPh, discusses why the drug is once again making headlines.  Discuss
What every dentist and team member should know about these 2 drugs
July 1, 2020 -- A new U.S. Food and Drug Administration (FDA) warning regarding gabapentin and pregabalin recently caught the eye of Tom Viola, RPh. Now, he has some advice to share with DrBicuspid.com readers on why the warning is something they should understand and heed.  Discuss
UTHSC secures $1.7M for opioid addiction studies
June 8, 2020 -- Researchers from the University of Tennessee Health Science Center (UTHSC) have been awarded $1.7 million from the U.S. National Institutes of Health to study the genetic factors of opioid addiction.
Podcast: Thoughts on pain control and prescriptions after COVID-19's rise
June 5, 2020 -- Tom Viola, RPh, has some advice to share with DrBicuspid.com readers on opioid usage and pain control as dental practices continue to move forward after the COVID-19 pandemic and subsequent disruption.  Discuss
Antipain center discovered in mice may lead to new painkillers
May 21, 2020 -- Scientists have discovered a small area in the brains of mice that dampens their sense of pain, which could eventually lead to new pain management treatments for humans, according to a study published on May 18 in Nature Neuroscience.  Discuss
Hot Topic
Second Opinion: Outpatient detoxification for opioid-addicted patients

While steps are needed to reduce the number of prescribed opioids in the U.S., what about those patients who may already be addicted and at risk? In this Second Opinion, Vikram Tarugu, MD, details a detoxification program that may be appropriate for your patients and your community. Read more.

Conferences
Parenteral Moderate Sedation Training for Dentists
November 6-23
Dallas, Texas United States
ACLS Training for Dentists and Staff
November 13
Dallas, Texas United States
Sedation Permit Renewal/Refresher for Dentistry
November 14
Dallas, Texas United States